Neuropsychiatric Disease and Treatment

ISSN: 1178-2021

Editor-in-Chief: Dr Roger M Pinder

1176-6328 (Print) - went to online only in 2009

An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

This journal offers Accelerated Publication.

Articles:

Latest articles:

- 5 records -

Review

Advances in the Application of Brain–Computer Interface-Based Neurofeedback Training in the Rehabilitation of Patients with Major Depressive Disorder

Liu J, Liu L, Chen H, Xuan S, Leng X

Neuropsychiatric Disease and Treatment 2026, 22:609788

Published Date: 25 June 2026

Original Research

Second-Generation Long-Acting Injectable Antipsychotics: A Comprehensive Assessment of Effectiveness, Safety, and Cost

Ifteni P, Petric PS, Popa AV, Teodorescu A, Georgescu R, Manea MC

Neuropsychiatric Disease and Treatment 2026, 22:606817

Published Date: 20 June 2026

Original Research

Resting-State EEG Characteristics of Tardive Dyskinesia: Spectral and Network Connectivity Insights

Yan L, Xie B, Sun Y, Zheng M, Wang J, Li Y, Chen J, Zhou S, Yu X, Yuan J

Neuropsychiatric Disease and Treatment 2026, 22:595872

Published Date: 20 June 2026

Original Research

Efficacy of Adjunctive Lumateperone 42 mg on Anhedonia and Across a Broad Range of Depressive Symptoms in Major Depressive Disorder: Post Hoc Analysis of a Phase 3, Randomized, Placebo-Controlled Trial

Thase ME, Earley WR, Kozauer SG, Chen C, Lakkis H, Durgam S

Neuropsychiatric Disease and Treatment 2026, 22:594893

Published Date: 19 June 2026

Review

Mini-Review: Allicin as a Potential Neuroprotective Compound in Neurological Disorders

Tang WR, Chen KQ

Neuropsychiatric Disease and Treatment 2026, 22:621474

Published Date: 18 June 2026